Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Merck & Co., Inc.    MRK   US58933Y1055

MERCK & CO., INC.

 (MRK)
56
Real-time Quote. Real-time BATS US - 05/22 04:59:59 pm
46.71 USD   -1.31%
9h agoDJU.S. HOT STOCK FUTURES: Hot stocks to watch
9h agoDJPfizer To Spin Off Remaining Zoetis Stake in Exchange Offer
16h ago Merck signs $5 billion share buyback agreement with Goldman Sachs
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Merck _ Co., Inc. : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales45 98748 04747 26745 23645 91746 453
Operating income (EBITDA)21 12323 01722 53418 68419 22120 744
Operating profit (EBIT)13 74215 59015 55613 85714 55315 166
Pre-Tax Profit (EBT)--9 232---
Net income8616 2726 6616 8508 9429 550
EPS ( $)0,282,022,162,222,913,33
Dividend per Share ( $)1,521,561,691,711,771,83
Yield3,21%3,30%3,57%3,62%3,73%3,86%
Announcement Date02/03/2011
12:00pm		02/02/2012
12:00pm		02/01/2013
12:00pm		---
Finances - Leverage
Merck _ Co., Inc. : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt5 6812 5434 428---
Finance---1 86210 50417 872
Operating income (EBITDA)21 12323 01722 53418 68419 22120 744
Leverage
(Debt/EBITDA)		0,27x0,11x0,20x---
Capital Expenditure1 6781 7231 9541 8311 9271 954
Book Value Per Share (BVPS)17,6 $17,9 $17,5 $18,1 $20,6 $22,4 $
Cash Flow per Share3,47 $4,00 $3,26 $4,52 $4,92 $5,67 $
Announcement Date02/03/2011
12:00pm		02/02/2012
12:00pm		02/01/2013
12:00pm		---
Balance Sheet Analysis
Merck _ Co., Inc. : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 142 918 M$ -
Company Value 141 056 M$ 132 414 M$
Valuation 2013e 2014e
PER (Price / EPS) 21,3x 16,3x
Capitalization / Revenue 3,16x 3,11x
EV / Revenue 3,12x 2,88x
EV / EBITDA 7,55x 6,89x
Yield (DPS / Price) 3,62% 3,73%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 30,6% 31,7%
operating laverage (Delta EBIT / Delta Sales) -2,54x 3,34x
Net Margin (Net Profit / Revenue) 15,1% 19,5%
ROA (Net Profit / Asset) 11,5% 11,2%
ROE (Net Profit / Equities) 19,0% 19,9%
Rate of Dividend 77,1% 60,8%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   4,05% 4,20%
Cash Flow / Sales (Taux d'autofinancement) 30,2% 32,4%
Capital Intensity (Assets / Sales) 1,31x 1,74x
Financial Leverage (Net Debt / EBITDA) -0,10x -0,55x
Price Earning Ratio
Merck _ Co., Inc. : Price Earning Ratio
EPS & Dividend
Merck _ Co., Inc. : EPS Dividend
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.